相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ETS transcription factors as emerging drug targets in cancer
Michael Hsing et al.
MEDICINAL RESEARCH REVIEWS (2020)
The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness
Liselot M. Mus et al.
SCIENTIFIC REPORTS (2020)
The Predictive Value of Estrogen Receptor 1 on Adjuvant Chemotherapy in Locally Advanced Colorectal Cancer: A Retrospective Analysis With Independent Validation and Its Potential Mechanism
Shu-Biao Ye et al.
FRONTIERS IN ONCOLOGY (2020)
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
G. Argiles et al.
ANNALS OF ONCOLOGY (2020)
Novel biomarkers for the diagnosis and prognosis of colorectal cancer
Hyung-Hoon Oh et al.
INTESTINAL RESEARCH (2020)
Promoter DNA Hypermethylation and Paradoxical Gene Activation
Jim Smith et al.
TRENDS IN CANCER (2020)
DNMT Inhibitors Increase Methylation in the Cancer Genome
Anil K. Giri et al.
FRONTIERS IN PHARMACOLOGY (2019)
The long-term survival characteristics of a cohort of colorectal cancer patients and baseline variables associated with survival outcomes with or without time-varying effects
Yajun Yu et al.
BMC MEDICINE (2019)
Genome-wide off-targets of drugs: risks and opportunities
Anil K. Giri et al.
CELL BIOLOGY AND TOXICOLOGY (2019)
ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet-derived growth factor BB
Xi Cheng et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Pharmacogenetic landscape of DPYD variants in south Asian populations by integration of genome-scale data
Judith M. Hariprakash et al.
PHARMACOGENOMICS (2018)
The Transcription Factor ETV5 Mediates BRAFV600E-Induced Proliferation and TWIST1 Expression in Papillary Thyroid Cancer Cells
Oorvashi Roy Puli et al.
NEOPLASIA (2018)
DPYD*2A and MTHFR C677T predict toxicity and efficacy, respectively, in patients on chemotherapy with 5-fluorouracil for colorectal cancer
Noor Ahmed Nahid et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
Global patterns and trends in colorectal cancer incidence and mortality
Melina Arnold et al.
GUT (2017)
Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies
M. Del Rio et al.
EUROPEAN JOURNAL OF CANCER (2017)
Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes
Sebastian Stintzing et al.
EUROPEAN JOURNAL OF CANCER (2017)
DNA methylation profiling reveals the presence of population-specific signatures correlating with phenotypic characteristics
Anil K. Giri et al.
MOLECULAR GENETICS AND GENOMICS (2017)
DPYD genotype-guided dose individualization to improve patient safety of fluoropyrimidine therapy: call for a drug label update
L. M. Henricks et al.
ANNALS OF ONCOLOGY (2017)
Subgroups and prognostication in stage III colon cancer: future perspectives for adjuvant therapy
E. Auclin et al.
ANNALS OF ONCOLOGY (2017)
Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment
Sarah Bazzocco et al.
CLINICAL CANCER RESEARCH (2015)
Adjuvant chemotherapy after preoperative (chemo) radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data
Anne J. Breugom et al.
LANCET ONCOLOGY (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients
Daniela Kandioler et al.
EBIOMEDICINE (2015)
A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data
Andrew E. Teschendorff et al.
BIOINFORMATICS (2013)
Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray
Yi-an Chen et al.
EPIGENETICS (2013)
Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value
Laetitia Marisa et al.
PLOS MEDICINE (2013)
ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells
Marta Llaurado et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics
Daniel Tabas-Madrid et al.
NUCLEIC ACIDS RESEARCH (2012)
PEA3/ETV4-related transcription factors coupled with active ERK signalling are associated with poor prognosis in gastric adenocarcinoma
R. Keld et al.
BRITISH JOURNAL OF CANCER (2011)
Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX® Colon Cancer Assay
Kim M. Clark-Langone et al.
BMC CANCER (2010)
Experimentally Derived Metastasis Gene Expression Profile Predicts Recurrence and Death in Patients With Colon Cancer
J. Joshua Smith et al.
GASTROENTEROLOGY (2010)
Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer
Robert N. Jorissen et al.
CLINICAL CANCER RESEARCH (2009)
Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
Richard M. Simon et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
DNA methylation inhibits p53-mediated survivin repression
N. H. Nabilsi et al.
ONCOGENE (2009)
Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factors
Stephanie Renaud et al.
NUCLEIC ACIDS RESEARCH (2007)
Epigenetic gene silencing in cancer: the DNA hypermethylome
Manel Esteller
HUMAN MOLECULAR GENETICS (2007)
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
CM Ribic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
